Literature DB >> 14625072

Losartan's molecular basis of interaction with membranes and AT1 receptor.

P Zoumpoulakis1, I Daliani, M Zervou, I Kyrikou, E Siapi, G Lamprinidis, E Mikros, T Mavromoustakos.   

Abstract

Physicochemical methods were used to study the thermal and dynamic changes caused by losartan in the membrane bilayers. In addition, molecular modeling was implemented to explore its topography both in membranes and AT(1) receptor. Its incorporation resulted in the modification of thermal profile of dipalmitoyl phosphatidylcholine (DPPC) bilayers in a concentration dependent way up to 20mol% as it is depicted from the combination of differential scanning calorimetry (DSC) and MAS data. In particular, the presence of losartan caused lowering of the phase transition temperature and abolishment of the pretransition. T(1) experiments revealed the location of the drug into the membrane bilayers. The use of a combination of biophysical methods along with docking experiments brought out a possible two-step mechanism which involves incorporation of losartan at the interface of membrane bilayers and diffusion in the upper parts of AT(1) receptor helices IV-VII.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625072     DOI: 10.1016/s0009-3084(03)00053-7

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  10 in total

1.  Comparison of thermal effects of stilbenoid analogs in lipid bilayers using differential scanning calorimetry and molecular dynamics: correlation of thermal effects and topographical position with antioxidant activity.

Authors:  Catherine Koukoulitsa; Serdar Durdagi; Eleni Siapi; Carolina Villalonga-Barber; Xanthippi Alexi; Barry R Steele; Maria Micha-Screttas; Michael N Alexis; Anna Tsantili-Kakoulidou; Thomas Mavromoustakos
Journal:  Eur Biophys J       Date:  2011-05-08       Impact factor: 1.733

2.  Use of small angle neutron scattering to study the interaction of angiotensin II with model membranes.

Authors:  Julia Preu; Timo Jaeger; Vasil M Garamus; Thomas Gutberlet
Journal:  Eur Biophys J       Date:  2011-02-03       Impact factor: 1.733

3.  Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.

Authors:  M T Le; M K Pugsley; G Vauquelin; I Van Liefde
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

4.  Development of a CP 31P NMR broadline simulation methodology for studying the interactions of antihypertensive AT1 antagonist losartan with phospholipid bilayers.

Authors:  Charalambos Fotakis; Dionisios Christodouleas; Petros Chatzigeorgiou; Maria Zervou; Nikolas-Ploutarch Benetis; Kyriakos Viras; Thomas Mavromoustakos
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

5.  Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.

Authors:  Navneet Kaur; Amardeep Kaur; Yogita Bansal; Dhvanit I Shah; Gulshan Bansal; Manjeet Singh
Journal:  Bioorg Med Chem       Date:  2008-10-29       Impact factor: 3.641

6.  The application of solid-state NMR spectroscopy to study candesartan cilexetil (TCV-116) membrane interactions. Comparative study with the AT1R antagonist drug olmesartan.

Authors:  Dimitrios Ntountaniotis; Tahsin Kellici; Andreas Tzakos; Pinelopi Kolokotroni; Theodore Tselios; Johanna Becker-Baldus; Clemens Glaubitz; Sonyan Lin; Alexandros Makriyannis; Thomas Mavromoustakos
Journal:  Biochim Biophys Acta       Date:  2014-06-16

7.  Comparison of the GPVI inhibitors losartan and honokiol.

Authors:  Marie-Blanche Onselaer; Magdolna Nagy; Chiara Pallini; Jeremy A Pike; Gina Perrella; Lourdes Garcia Quintanilla; Johannes A Eble; Natalie S Poulter; Johan W M Heemskerk; Steve P Watson
Journal:  Platelets       Date:  2019-03-08       Impact factor: 3.862

Review 8.  On the Rational Drug Design for Hypertension through NMR Spectroscopy.

Authors:  Eleni Chontzopoulou; Andreas G Tzakos; Thomas Mavromoustakos
Journal:  Molecules       Date:  2020-12-22       Impact factor: 4.411

9.  Micro-pharmacokinetics: Quantifying local drug concentration at live cell membranes.

Authors:  Karolina Gherbi; Stephen J Briddon; Steven J Charlton
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

Review 10.  Ligands, their receptors and ... plasma membranes.

Authors:  G Vauquelin; A Packeu
Journal:  Mol Cell Endocrinol       Date:  2009-07-30       Impact factor: 4.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.